Infectious Disease Diagnostics Testing Market Trends, Drivers, and Regional Analysis 2025–2029
Uncover key drivers, emerging technologies, and competitive movements shaping the infectious disease diagnostics testing market from 2025–2034 with trusted insights from The Business Research Company
How Is The Infectious Disease Diagnostics Testing Market Size Expected To Expand Over 2029-2034?
The infectious disease diagnostics testing market size has experienced robust expansion over the past few years. It is projected to expand from $38.52 billion in 2024 to $42.24 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.7%. This historical expansion can be linked to factors such as an increase in disease outbreaks like SARS, Ebola, and Zika; heightened awareness among medical professionals and the general populace regarding the significance of prompt detection and avoidance of infectious ailments; an uptick in government-sponsored initiatives for monitoring, managing, and preventing diseases; the greater ease with which infectious diseases spread due to increased global travel and commerce; and enhanced expenditure on healthcare, especially in developing economies.
The infectious disease diagnostics testing market size is anticipated to experience robust growth in the coming years. It is projected to expand to $60.71 billion by 2029, achieving a compound annual growth rate (CAGR) of 9.5%. This projected growth is driven by the continuous emergence of novel pathogens, such as new strains of influenza or COVID-19es, the increasing focus on personalized medicine and targeted therapies, a rising demand for rapid and on-site testing solutions, a greater emphasis on epidemiological surveillance and early detection systems, and heightened research and development activities aimed at creating novel diagnostic technologies and biomarkers. Significant trends during this forecast period involve the miniaturization and portability of diagnostic devices, the adoption of multiplex assays capable of simultaneously detecting multiple pathogens, the integration of digital health solutions like mobile apps and telemedicine platforms, the utilization of next-generation sequencing (NGS) technologies in infectious disease diagnostics, advancements in biosensor technologies for quick and sensitive identification of infectious agents, and the incorporation of AI and machine learning algorithms into diagnostic platforms.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp
Which Market Factors Are Fueling The Infectious Disease Diagnostics Testing Industry Growth?
The infectious disease diagnostic testing market is projected to grow due to an anticipated increase in respiratory infections. These infections impact the respiratory system, including the nose, throat, airways, and lungs. The rising incidence of respiratory infections is attributed to viral and bacterial transmission through close contact with infected individuals, insufficient hygiene practices, crowded living conditions, and seasonal shifts in weather patterns. Infectious disease diagnostic testing is vital for diagnosing and managing respiratory infections because it can precisely identify pathogens such as bacteria and viruses in patient samples. For example, the Canadian Institute for Health Information, a Canada-based non-profit organization, stated in February 2024 that hospitalizations for acute upper respiratory infections rose by 32% from 2,114 in 2022 to 2,797 cases in 2023. Therefore, the increase in respiratory infections is a key factor driving the infectious disease diagnostic testing market.
Which Categories Are Covered In The Infectious Disease Diagnostics Testing Market Segmentation Analysis?
The infectious disease diagnostics testingmarket covered in this report is segmented –
1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases, Liver
3) By End-User: Diagnostic Laboratories, Hospitals And Clinics, Academic Research Institutes, Other End-Users
Subsegments:
1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs), Next-Generation Sequencing (NGS), Microarray-Based Tests
2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR
Which Market Trends Are Expected To Define The Future Of The Infectious Disease Diagnostics Testing Market?
Leading companies within the infectious disease diagnostic testing market are concentrating on developing innovative technologies, such as molecular diagnostics platforms, to maintain their market presence. Molecular diagnostics platforms are sophisticated systems designed for detecting and analyzing nucleic acids (DNA or RNA) from biological samples for diagnostic purposes. As an illustration, in May 2022, Becton Dickinson, and Company, a US-based medical technology enterprise, unveiled the BD COR System, a fully automated, high-throughput molecular diagnostics platform for infectious diseases. This platform integrates and automates the entire molecular laboratory workflow, from sample processing to diagnostic results, thereby removing the necessity for manual specimen sorting and enabling lab technicians to focus on higher-value activities. The system has the capacity to process up to 1,700 specimens and deliver results within 24 hours, providing high-throughput functionalities and advanced genotyping for conditions like HPV and STIs.
Which Organizations Are At The Forefront Of The Infectious Disease Diagnostics Testing Market?
Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Myriad Genetics Inc., Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC, Biodesix Inc., Helix OpCo LLC, Inovio Pharmaceuticals Inc.
Download The Full Report Here:
Which Geographic Areas Are Driving Strong Demand For The Infectious Disease Diagnostics Testing Market?
North America was the largest region in the infectious disease diagnostics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=15831&type=smp
Browse Through More Reports Similar to the Global Infectious Disease Diagnostics Testing Market 2025, By The Business Research Company
Non Animal Alternatives Testing Global Market Report 2025
Pharmaceutical Sterility Testings Global Market Report 2025
Pcr And Realtime Pcr Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pcr-and-realtime-pcr-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
